Regeneron Pharmaceuticals
REGN
#255
Rank
S$100.74 B
Marketcap
$921.48
Share price
-1.99%
Change (1 day)
-29.39%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.37

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $50.27. In 2022 the company made an earnings per share (EPS) of $54.52 a decrease over its 2021 EPS that were of $102.86.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.37-7.61%
2022$54.52-47%
2021$102.86133.36%
2020$44.0869.13%
2019$26.06-14.44%
2018$30.46100.71%
2017$15.1831.78%
2016$11.5238.96%
2015$8.2972.55%
2014$4.80-17.55%
2013$5.83-44.98%
2012$10.59-422.54%
2011-$3.2892.13%
2010-$1.7149.41%
2009-$1.14-15.84%
2008-$1.36-36.88%
2007-$2.15-9.6%
2006-$2.384.12%
2005-$2.29-323.68%
2004$1.02-135.51%
2003-$2.88-24.38%
2002-$3.8156.35%
2001-$2.44187.3%
2000-$0.85-16%
1999-$1.01177.78%
1998-$0.36-35.71%
1997-$0.57-68.42%
1996-$1.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.04-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.53-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.84-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.95-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.03-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.28-91.49%๐Ÿ‡ซ๐Ÿ‡ท France